Adaptive designs can make clinical trials more flexible by
utilising results accumulating in the trial to modify the trial’s
course in accordance with pre-specified rules.
- There are more efficient, informative.
- They often make better use of resources such as time and money,
and might require fewer participants.
- Adaptive designs can be applied across all phases of clinical
research, from early-phase dose escalation to confirmatory
trials.
- Adaptive designs (ADs) provide an alternative. They have been
described as ‘planning to be flexible‘driving with one’s eyes open’
or ‘taking out insurance’ against assumptions. They add a
review–adapt loop to the linear design–conduct–analysis sequence
.
- Traditionally, clinical trials have been run in three steps
[
The trial is designed.
The trial is conducted as prescribed by the design.
Once the data are ready, they are analysed according to a
pre-specified analysis plan.
This practice is straightforward, but clearly inflexible as it
does not include options for changes that may become desirable or
necessary during the course of the trial.